Benefit-Cost Analyses for Vaccination Against Pneumococcous, Rotavirus, Haemophilus Influenza type B, and other Vaccine-Preventable Diseases

, , ,

Principal Investigator:
David Bloom, Chair, Department of Global Health and Population and Clarence James Gamble Professor of Economics and Demography

Department of Global Health and Population

Dates of Research:
December 1, 2007 — March 31, 2009


This project will conduct a series of preliminary analyses aimed at quantifying and accounting for the full benefits of different vaccination programs- with emphasis (in some of these studies) on externality effects, as well as on improved physical and cognitive development among children. The proposed focal points are as follows: 1) the impact of vaccine-preventable childhood diseases on lifetime employment and earnings; 2) the impact of childhood illness on parents’ work attendance and earnings; 3) children’s physical development, school attendance, educational attainment, and test scores, all in relation to future earnings; and 4) herd immunity effects associated with the health and economic benefits that immunization programs confer on non-immunized children and adults.